AXITINIB

Trials studying AXITINIB

• phase2A Study of AK104 Monotherapy or AK104 Plus Axitinib in Advanced/Metastatic Renal Cell Carcinomacompletedn=28
• phase1Study of PF-07265807 in Participants With Metastatic Solid Tumors.terminatedn=88
• phase2Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancerrecruitingn=224
• phase2SLM + Axitinib for Clear Cell RCCcompletedn=45
• phase2Axitinib Monotherapy With Early Dynamic Contrast Enhanced Ultrasound Monitoring in Chemorefractory Third Line Metastatic Colorectal Cancercompletedn=52
• phase3Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closingactive not recruitingn=68
• phase1A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180) [MK-3475A] In Advanced Solid Tumors (MK-3475A-C18)active not recruitingn=72
• phase2Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)recruitingn=720